Respiratory Emissions in Healthy Participants
1 other identifier
interventional
40
1 country
1
Brief Summary
This is an randomised cross over trial in healthy participants measuring respiratory emissions during different respiratory activities.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable healthy
Started Mar 2022
Longer than P75 for not_applicable healthy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 8, 2021
CompletedFirst Posted
Study publicly available on registry
December 27, 2021
CompletedStudy Start
First participant enrolled
March 8, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 9, 2025
CompletedJanuary 10, 2025
January 1, 2025
12 months
December 8, 2021
January 8, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Count of total number of respiratory particles emitted during respiratory activities in the range of 0.3 to 25 microns
Particles emitted will be counted using two different optical particle counters
Emission of particles will be collected and analysed for 2 minutes during each experimental condition
Study Arms (3)
Respiratory Activity 1
EXPERIMENTALRespiratory Activity 2
EXPERIMENTALRespiratory Activity 3
EXPERIMENTALInterventions
participants will perform a series of exertional respiratory activities
Eligibility Criteria
You may qualify if:
- Adults, over the age of 18 and able to give informed consent
- Symptom free from any respiratory illness in the last 48 hours
You may not qualify if:
- Pregnant (where the participant feels that their pregnancy will make participation uncomfortable)
- Inability to give consent
- Current respiratory disease. Participants with well controlled asthma will be included (defined as asthma that the participant self-rates their asthma as being under control and that does not limit exercise, work)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fisher and Paykel Healthcare
Auckland, 2013, New Zealand
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 8, 2021
First Posted
December 27, 2021
Study Start
March 8, 2022
Primary Completion
March 1, 2023
Study Completion
January 9, 2025
Last Updated
January 10, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will not share